(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 27869.20 | 28937.50 | -3.69 | 27869.20 | 28937.50 | -3.69 | 112871.40 | 158236.80 | -28.67 |
| Other Income | 387.10 | 439.50 | -11.92 | 387.10 | 439.50 | -11.92 | 6709.90 | 5898.60 | 13.75 |
| PBIDT | 2809.70 | 4547.60 | -38.22 | 2809.70 | 4547.60 | -38.22 | 21443.90 | 47096.90 | -54.47 |
| Interest | 78.50 | 50.60 | 55.14 | 78.50 | 50.60 | 55.14 | 169.40 | 286.80 | -40.93 |
| PBDT | 2731.20 | 4497.00 | -39.27 | 2731.20 | 4497.00 | -39.27 | 20527.40 | 46810.10 | -56.15 |
| Depreciation | 1030.50 | 1146.50 | -10.12 | 1030.50 | 1146.50 | -10.12 | 4152.60 | 4880.00 | -14.91 |
| PBT | 1700.70 | 3350.50 | -49.24 | 1700.70 | 3350.50 | -49.24 | 16374.80 | 41930.10 | -60.95 |
| TAX | 479.10 | 1199.80 | -60.07 | 479.10 | 1199.80 | -60.07 | 1827.70 | 10801.00 | -83.08 |
| Deferred Tax | -89.90 | -234.60 | -61.68 | -89.90 | -234.60 | -61.68 | -1969.30 | 367.60 | -635.72 |
| PAT | 1221.60 | 2150.70 | -43.20 | 1221.60 | 2150.70 | -43.20 | 14547.10 | 31129.10 | -53.27 |
| Equity | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 |
| PBIDTM(%) | 10.08 | 15.72 | -35.85 | 10.08 | 15.72 | -35.85 | 19.00 | 29.76 | -36.17 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.45 |
| Dr. Reddys Lab | 1235.50 |
| Cipla | 1236.00 |
| Zydus Lifesciences | 939.75 |
| Lupin | 2332.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: